Search Constraints
« Previous |
21 - 39 of 39
|
Next »
Search Results
Select an image to start the slideshow
Effects of pharmacological dopamine β-hydroxylase
inhibition on cocaine-induced behavior and neurochemistry
1 of 19
Moduation of post-synaptic ion channels by CaMKII
2 of 19
Intrinsic and Synaptic Determinants of Spike Timing Revealed by
Phase Response Analyses of a Morphological Globus Pallidus Neuron
Model
3 of 19
Cholinergic Interneurons: Distribution and Synaptic Inputs in the
Primate Putamen
4 of 19
Glutamatergic Inputs to the Monkey Subthalamic Nucleus: A
Comparison of Relative Abundance, Synaptology and Functional
Connectivity in Normal versus Parkinsonian Conditions.
5 of 19
Molecular Pathogenesis of DYT1 Dystonia
6 of 19
Impaired vesicular storage of norepinephrine and serotonin in Parkinson's disease-related pathogenesis
7 of 19
Regulation of Drosophila Synaptic Function and Plasticity by a
Schizophrenia Susceptibility Network.
8 of 19
Effects of 5-HT2A Receptor Antagonism on Cocaine
Self-administration, Cocaine-induced Reinstatement, and
Cocaine-induced Dopamine Overflow in Rhesus Monkeys
9 of 19
Subcellular & Subsynaptic Localization of Group IMetabotropic Glutamate Receptors in the Nucleus Accumbens
10 of 19
Ubiquitin C-terminal hydrolase regulation and dysfunction in
neurodegenerative disease pathogenesis
11 of 19
Regulation of Glutamate Transporter and Receptor Function by the
NHERF Scaffolding Proteins
12 of 19
Molecular Pathogenesis of Charcot-Marie-Tooth disease caused by
mutations in SIMPLE
13 of 19
Molecular Basis of NMDA Receptor Allosteric Regulation by New
Subunit-selective Modulators
14 of 19
Microcircuitry of Group IIIMetabotropic Glutamate Receptors (mGluRs) in the Mouse Striatum
15 of 19
Structural Plasticity of GABAergic and Glutamatergic Terminals in the Ventral Motor and Caudal Intralaminar Thalamic Nuclei in MPTP-treated Parkinsonian Monkeys
16 of 19
The study of Hebbian-type repetitive transcranial magnetic stimulation on impaired hand motor function in chronic stroke
17 of 19
Pharmacologically targeting the GABA-A receptors in neurological disease
18 of 19
Direct reprogramming of astrocytes to enhance recovery after stroke
19 of 19